Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Jennifer Helfer

- PMLiVE

Patient disengagement

Understanding the why

Health Literacy Explained

Hear from Dr Elizabeth Walder, author of a series of patient-focused e-books in plain english and why health literacy is so important.

Cuttsy + Cuttsy

patient engagement wheel

So how do you really engage with patients?

The most valuable insights from patient engagement are the most unexpected ones. Simple things, which may seem unimportant to you, may be the key to making patients’ lives easier and...

Cuttsy + Cuttsy

- PMLiVE

Avoiding data pitfalls in clinical research

Genomics sequencing and sensors will present new challenges

Perspective on biotech

In this supplementary issue of Perspective, we reveal the emerging technologies taking the biotech world by storm and ask if the definition of a biotech organisation needs updating.

Blue Latitude Health

How to be a patient

Doctors are trained on how to manage their patients. Now Which? magazine has published a guide for patients on how to get the most out of their GP

Life Healthcare Communications

Are rare disease companies naturally more patient-centric?

Intuitively it would make sense for these firms to be more connected with their patients

Will gene therapies finally be commercially viable to pharma?

Our latest Free Thinking white paper explores the science behind the idea of gene therapy and takes a look at some of the core challenges medical researchers have faced when...

Research Partnership

Living with Lupus: Breaking the Silence

Published in eyeforpharma July 2017 by Mariel Metcalfe

Research Partnership

- PMLiVE

A Spotlight on Healthcare Communications Advocacy by Alastair Kent

Earlier this year I received an email from Stefi Rucci asking me if I would mind if she nominated me for the Healthcare Advocate of the Year at this year’s...

Say Communications

- PMLiVE

Is it time we stopped talking about adherence?

Delivering a fresh approach to patient care

- PMLiVE

Spark closes on first US gene therapy approval

FDA starts review of Luxturna for patients with inherited retinal disease

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links